Resources | National Pharmaceutical Council

Showing 13 Results

NPC Comments on PCORI's Proposed Principles for the Consideration of the Full Range of Outcomes Data

NPC offered public feedback to PCORI on its new mandate to consider the full range of patient-centered outcomes in its research.

NPC Responses to NQF’s request for comments on the Patient-Reported Outcomes Draft Recommendations Report

NPC Comments on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021

NPC Comments on Public Request for Input on Cures 2.0

NPC Provides Public Input to Guide ICER's Selection of Non-Drug Assessment Topics for 2020

NPC Comments on Proposed Changes for ICER 2020 Value Assessment Framework

NPC Comments on ICER's Value Assessment Methods for Single or Short-Term Transformative Therapies

Improving Health Care Quality Through CER and VBID

NPC Testifies on Priorities for Comparative Effectiveness Research

It’s Critical to Get Comparative Effectiveness Research Right

NPC Testifies on Priorities for Comparative Effectiveness Research

IOM, AHRQ and the FCCCER discuss funding CER

NPC Testifies on Priorities for Comparative Effectiveness Research